Active Stocks
Tue Apr 16 2024 15:59:30
  1. Tata Steel share price
  2. 160.05 -0.53%
  1. Infosys share price
  2. 1,414.75 -3.65%
  1. NTPC share price
  2. 359.40 -0.54%
  1. State Bank Of India share price
  2. 751.90 -0.65%
  1. HDFC Bank share price
  2. 1,509.40 0.97%
Business News/ Companies / News/  MedGenome Labs ventures into D2C biz; offers easy genetic screening services
BackBack

MedGenome Labs ventures into D2C biz; offers easy genetic screening services

MedGenome Labs, which operates one of the biggest genomic testing labs with specialised tests in South Asia, will initially offer two tests - Kardiogen and Curegen under the umbrella of personal genomics.

MedGenome will offer specialised, evidence-based genetic screening tests that can be ordered online through the Genessense website or via e-commerce platforms in future.Premium
MedGenome will offer specialised, evidence-based genetic screening tests that can be ordered online through the Genessense website or via e-commerce platforms in future.

NEW DELHI: MedGenome Labs, a genomics and clinical data-driven diagnostics and drug discovery research company, on Wednesday launched its direct-to-consumer category under the brand Genessense for consumers in India.

MedGenome will offer specialised, evidence-based genetic screening tests that can be ordered online through the Genessense website or via e-commerce platforms in future.

The company, which operates one of the biggest genomic testing labs with specialised tests in South Asia, will initially offer two tests - Kardiogen and Curegen under the umbrella of personal genomics.

Kardiogen will be India’s first polygenic risk score based predictive test for coronary artery disease with a proven specificity of 90% for Indian population. Curegen is a genome-based drug response test that will outline individual’s reaction to different drugs or medications. The test will help consumers avoid adverse drug reactions and improving response to medications.

"Heart diseases caused by gene mutations are rare, however, it can be fatal. While the awareness to identify these mutations in the patients is increasing, we also need to understand that myocardial infarction/CAD (common specially in the young) can also be strongly influenced by genes. Millions of gene variants together influence the onset of this disease and can result in death at a younger age, but it is a strong interplay with lifestyle, diet, and risk factors," said Vedam Ramprasad, CEO, MedGenome, said.

In a first, these tests have been developed and validated on South Asian and Indian population groups by MedGenome

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 29 Sep 2021, 04:45 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App